Concepedia

Rodolfo Mattioli

RM

36

Publications

1.8K

Citations

21

H-Index

1984

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Ospedale San Carlo

European Institute of Oncology

Ospedale Papa Giovanni XXIII

Istituto Oncologico Veneto

Rodolfo Mattioli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1984–2021

36

Publications

36

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · Journal of Clinical Oncology · 2007 · 264 citations · Full text

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Francesco Cognetti, Enzo Maria Ruggeri, Alessandra Felici et al. · Annals of Oncology · 2011 · 220 citations · Full text

, , +7

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan‐based chemotherapy

Cristian Massacesi, Salvatore Terrazzino, F. Marcucci et al. · Cancer · 2006 · 116 citations · Full text

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

Francesco Di Costanzo, Paolo Carlini, Laura Doni et al. · British Journal of Cancer · 2005 · 98 citations · Full text

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 89 citations · Full text

, , +10

Rows per page

1–5 of 36